Effects of obesity on pulmonary function considering the transition from obstructive to restrictive pattern from

Li Huang1, Sen-Te Wang1,2, Han-Pin Kuo3

  • 1Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan.

Insights

Obesity impairs lung function in children, causing an obstructive pattern. This pattern shifts to a restrictive pattern in adulthood, with effects changing based on age and sex.

Area of Science:

  • Pulmonary Medicine
  • Pediatric Obesity

Background:

  • Obesity is linked to distinct pulmonary function patterns in adults (restrictive) and children (obstructive).
  • The transition of these patterns from childhood to adulthood remains incompletely understood.

Purpose of the Study:

  • To systematically review and analyze studies on body mass index and pulmonary function in children and young adults.
  • To elucidate the evolving impact of obesity on lung function across different age groups.

Main Methods:

  • Systematic literature search for studies correlating body mass index with pulmonary function tests.
  • Inclusion of 17 studies comparing pulmonary function (FEV1, FVC, FEV1/FVC) in individuals with and without obesity.
  • Application of random-effects models to calculate pooled estimates of mean differences.

Main Results:

  • Individuals with obesity exhibited a lower FEV1/FVC ratio and higher percent-predicted FVC compared to normal-weight individuals.
  • Obesity induced an obstructive pulmonary function pattern in childhood, peaking around age 16 in boys and 20 in girls.
  • Pulmonary effects shifted towards a restrictive pattern after age 30-40, varying by sex.

Conclusions:

  • Obesity significantly impairs pulmonary function, initiating with an obstructive pattern in youth and transitioning to a restrictive pattern in adulthood.
  • The age and sex-specific progression of obesity-related pulmonary dysfunction highlights the need for tailored interventions.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
785
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.4K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
34
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
33